Researchers from Harvard University's School of Public Health, Huazhong University of Science and Technology in China, and National University of Singapore estimated that 11.7 per cent of cases of type two diabetes in men and 2.4 per cent in women (27.8 million cases in total worldwide) might be attributable to active smoking. They also found the risk decreases as time elapses after smokers quit. "Cigarette smoking should be considered a key modifiable risk factor for diabetes. Public health efforts to reduce smoking will have a substantial impact on the global burden of type two diabetes," said co-author Frank Hu, professor at the Harvard T H Chan School of Public Health.
While the evidence pointing to smoking as a risk factor for cancer, respiratory diseases, and cardiovascular disease is overwhelming, corroboration of a link between smoking and type two diabetes risk has been slower to build. In the study, researchers conducted a meta-analysis of 88 previous studies on the association between smoking and type two diabetes risk, looking at health data from nearly six million study participants.
They found that when compared with people who never smoked, current smoking increased the risk of type two diabetes by 37 per cent; former smoking by 14 per cent; and passive smoking (breathing in second-hand smoke) by 22 per cent. They also found a 54 per cent increased risk of type two diabetes in people who quit smoking less than five years ago, which fell to 18 per cent increased risk after five years and 11 per cent increased risk more than 10 years after quitting.
The increased risk of developing type two diabetes was 21 per cent, 34 per cent, and 57 per cent for light, moderate, and heavy smokers, respectively, compared with those who never smoked."
Despite the global efforts to combat the tobacco epidemic, cigarette use remains the leading cause of mortality and morbidity across the world," said first author An Pan, professor at the Huazhong University of Science and Technology. The study was published in The Lancet Diabetes and Endocrinology Journal.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)